2G Energy AG (2GB)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 44.48 |
|---|---|
| 52-week range | 24.90 – 76.25 |
| Return, 1 month / 3 months | −31.8% / −29.0% |
| Return, 1 year / 3 years | +39.1% / +112.8% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 60.7% |
| Worst drawdown (1 year) | -39.8% |
| Average daily value traded | 2.78M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
2G Energy AG designs and manufactures combined heat and power systems, known as cogeneration units, that produce electricity and usable heat at the same time. Its plants run on fuels such as natural gas, biogas and hydrogen, and are installed for industrial firms, municipal utilities, farms and other customers who need power and heat on site. The company is based in Heek, in Germany, and also provides servicing and maintenance for its installed units.
2G Energy AG trades under the code 2GB on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
2G Energy AG (2GB) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 44.48 on 23 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 454 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.1% and over the last three months it fell 29.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.7% | ||
| From 52-week high | -40.0% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -29.0% | ||
| 6-month return | -10.5% | ||
| 12-month return, skipping the last month | 103.9% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 60.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.8% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 2.78M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.0% |
|---|---|
| 1 month | −31.8% |
| 3 months | −29.0% |
| 6 months | −10.5% |
| 1 year | +39.1% |
| 3 years | +112.8% |
| 5 years | +52.6% |
Signals
| 50-day / 200-day average | 55.83 / 51.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | EUR 0.2100 |
| 13 Jun 2025 | EUR 0.2000 |
| 5 Jun 2024 | EUR 0.1700 |
| 14 Jun 2023 | EUR 0.1400 |
| 6 Jun 2022 | EUR 0.5000 |
| 16 Jun 2021 | EUR 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.